Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2025-12-24 @ 10:34 PM
NCT ID:
NCT00038935
Eligibility Criteria:
Inclusion Criteria:
* Severe hemophilia A (FVIII:C \< 1% at local laboratory)
* Previously treated patients (PTP) with at least 250 exposure days to any factor VIII product
* Age greater than or equal to 12 years\\
Exclusion Criteria:
* The presence of any bleeding disorder in addition to hemophilia A
* Concomitant therapy with immunosuppressant drugs (e.g., intravenous immunoglobulin (IVIG), routine systemic corticosteroid use)
* History of detectable factor VIII inhibitor
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Study:
NCT00038935
Study Brief:
Protocol Section:
NCT00038935